Biomarkers of ineffective erythropoiesis predict response to Luspatercept in patients with low or intermediate-1 risk Myelodysplastic Syndromes (MDS): final results from the phase 2 PACE-MDS study

Platzbecker, Uwe, Germing, Ulrich, Giagounidis, Aristoteles, Goetze, Katharina, Kiewe, Philipp, Mayer, Karin Tina, Ottmann, Oliver, Radsak, Markus, Wolff, Thomas, Haase, Detlef, Hankin, Monty, Wilson, Dawn, Zhang, Xiaosha, Laadem, Abderrahmane, Sherman, Matthew L. and Attie, Kenneth M. 2015. Biomarkers of ineffective erythropoiesis predict response to Luspatercept in patients with low or intermediate-1 risk Myelodysplastic Syndromes (MDS): final results from the phase 2 PACE-MDS study. Blood 126 (23) , 2862.

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	American Society of Hematology
ISSN:	0006-4971
Last Modified:	14 Jun 2019 09:53
URI:	https://orca.cardiff.ac.uk/id/eprint/96760

Actions (repository staff only)

Edit Item